SILO PHARMA INC (SILO:NASDAQ)
$6.13 0.8785 (16.7286%)
Analysed SILO PHARMA INC (SILO:NASDAQ) News Sources
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
07-07-2025
yahoo.com
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
16-07-2025
yahoo.com
Silo Pharma Second Quarter 2025 Earnings: US$0.19 loss per share (vs US$0.30 loss in 2Q 2024)
15-08-2025
yahoo.com
EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers
02-09-2025
yahoo.com
Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug
09-09-2025
yahoo.com
EXCLUSIVE: Silo Pharma Partners With Fireblocks To Advance Crypto Treasury Strategy Acquisition And Security
23-09-2025
yahoo.com
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
23-09-2025
yahoo.com
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
29-09-2025
yahoo.com
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
01-10-2025
yahoo.com
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
04-05-2026
yahoo.com
What is the current price of SILO PHARMA INC (SILO:NASDAQ)?
The current price of SILO PHARMA INC (SILO:NASDAQ) is $6.13.
SILO PHARMA INC (SILO:NASDAQ) absolute price change since previous trading day?
The absolute price change of SILO PHARMA INC (SILO:NASDAQ) since the previous trading day is $0.8785.
SILO PHARMA INC (SILO:NASDAQ) percentage price change since previous trading day?
The percentage price change of SILO PHARMA INC (SILO:NASDAQ) since the previous trading day is 16.7286%.
What is the most recent average sentiment score for SILO PHARMA INC (SILO:NASDAQ)?
The most recent average sentiment score for SILO PHARMA INC (SILO:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for SILO PHARMA INC (SILO:NASDAQ)?
The most recent sentiment for SILO PHARMA INC (SILO:NASDAQ) is .
SEC-8K** Filing Available For SILO PHARMA INC (SILO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.